Authors:
LaVaute, T
Smith, S
Cooperman, S
Iwai, K
Land, W
Meyron-Holtz, E
Drake, SK
Miller, G
Abu-Asab, M
Tsokos, M
Switzer, R
Grinberg, A
Love, P
Tresser, N
Rouault, TA
Citation: T. Lavaute et al., Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice, NAT GENET, 27(2), 2001, pp. 209-214
Authors:
Fischereder, M
Schneeberger, H
Lohse, P
Kramer, BK
Schlondorff, D
Land, W
Citation: M. Fischereder et al., Increased rate of renal transplant failure in patients with the G20210A mutation of the prothrombin gene, AM J KIDNEY, 38(5), 2001, pp. 1061-1064
Authors:
Fischereder, M
Luckow, B
Hocher, B
Wuthrich, RP
Rothenpieler, U
Schneeberger, H
Panzer, U
Stahl, RAK
Hauser, IA
Budde, K
Neumayer, HH
Kramer, BK
Land, W
Schlondorff, D
Citation: M. Fischereder et al., CC chemokine receptor 5 and renal-transplant survival, LANCET, 357(9270), 2001, pp. 1758-1761
Authors:
Lederer, SR
Kluth-Pepper, B
Schneeberger, H
Albert, E
Land, W
Feucht, HE
Citation: Sr. Lederer et al., Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts, KIDNEY INT, 59(1), 2001, pp. 334-341
Citation: W. Land et Mr. Weir, Approaches to improve allograft half-life III: Practical aspects of sparing and switching maneuvers - Foreword, TRANSPLAN P, 33(4), 2001, pp. 1S-1S
Authors:
Land, W
Schneeberger, H
Weiss, M
Ege, T
Stumpfig, L
Citation: W. Land et al., Mycophenolate mofetil monotherapy: An optimal, safe, and efficacious immunosuppressive maintenance regimen in kidney transplant patients, TRANSPLAN P, 33(4), 2001, pp. 29S-35S
Authors:
Stangl, M
Zerkaulen, T
Theodorakis, J
Illner, W
Schneeberger, H
Land, W
Faist, E
Citation: M. Stangl et al., Influence of brain death on cytokine release in organ donors and renal transplants, TRANSPLAN P, 33(1-2), 2001, pp. 1284-1285
Authors:
Squifflet, JP
Backman, L
Claesson, K
Dietl, KH
Ekberg, H
Forsythe, JLR
Kunzendorf, U
Heemann, U
Land, W
Morales, JM
Muhlbacher, F
Talbot, D
Taube, D
Tyden, G
van Hooff, J
Schleibner, S
Vanrenterghem, Y
Citation: Jp. Squifflet et al., Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients, TRANSPLANT, 72(1), 2001, pp. 63-69
Citation: W. Land, Satellite Symposium of the 9th Congress of the European Society for Organ Transplantation, Oslo, Norway - Foreword, TRANSPLAN P, 32(1A), 2000, pp. 1S-1S
Authors:
Keunecke, C
Rothenpieler, U
Zanker, B
Schneeberger, H
Illner, WD
Theodorakis, J
Stangl, M
Land, W
Citation: C. Keunecke et al., Mycophenolate mofetil monotherapy: An example of a safe nephrotoxicity/atherogenicity-free immunosuppressive maintenance regimen in a selected group of kidney-transplanted patients, TRANSPLAN P, 32(1A), 2000, pp. 6S-8S
Authors:
Theodorakis, J
Schneeberger, H
Illner, WD
Stangl, M
Zanker, B
Land, W
Citation: J. Theodorakis et al., Nephrotoxicity-free, mycophenolate mofetil-based induction/maintenance immunosuppression in elderly recipients of renal allografts from elderly cadaveric donors, TRANSPLAN P, 32(1A), 2000, pp. 9S-11S
Authors:
Kreis, H
Cisterne, JM
Land, W
Wramner, L
Squifflet, JP
Abramowicz, D
Campistol, JM
Morales, JM
Grinyo, JM
Mourad, G
Berthoux, FC
Brattstrom, C
Lebranchu, Y
Vialtel, P
Citation: H. Kreis et al., Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients, TRANSPLANT, 69(7), 2000, pp. 1252-1260
Authors:
Undre, NA
van Hooff, J
Christiaans, M
Vanrenterghem, Y
Donck, J
Heeman, U
Kohnle, M
Zanker, B
Land, W
Morales, JM
Andres, A
Schafer, A
Stevenson, P
Citation: Na. Undre et al., Low systemic exposure to tacrolimus correlates with acute rejection, TRANSPLAN P, 31(1-2), 1999, pp. 296-298
Citation: W. Land, Postischemic reperfusion injury and allograft dysfunction: Is allograft rejection the result of a fateful confusion by the immune system of danger and benefit?, TRANSPLAN P, 31(1-2), 1999, pp. 332-336
Authors:
Zanker, B
Rothenpieler, U
Kubitza, A
Schneeberger, H
Hillebrand, G
Land, W
Citation: B. Zanker et al., Nonnephrotoxic, nonatherogenic maintenance therapy in kidney-transplanted patients using MMF-monotherapy: A pilot study, TRANSPLAN P, 31(1-2), 1999, pp. 1142-1143
Authors:
Zanker, B
Sohr, B
Eder, M
Frohmann, E
Land, W
Citation: B. Zanker et al., Comparison of MPA trough levels in patients with severe diabetes mellitus and from non-diabetics after transplantation, TRANSPLAN P, 31(1-2), 1999, pp. 1167-1167
Authors:
Hillebrand, GF
Schlosser, S
Schneeberger, H
Lorenz, B
Zanker, B
Samtleben, W
Land, W
Citation: Gf. Hillebrand et al., No clinical evidence of hyperlipidemia as a risk factor for chronic renal allograft failure, TRANSPLAN P, 31(1-2), 1999, pp. 1391-1392
Authors:
Mellinghoff, AC
Reininger, AJ
Land, W
Abendroth, D
Hepp, KD
Landgraf, R
Citation: Ac. Mellinghoff et al., Cardiovascular risk profile after simultaneous pancreas and kidney transplantation, EXP CL E D, 106(6), 1998, pp. 460-464
Citation: W. Land, Proceedings of an international symposium on postischemic reperfusion injury and kidney transplantation, Zurs, Austria, January 9-11, 1997 - Foreword, TRANSPLAN P, 30(8), 1998, pp. 4209-4209